Company: Raytelligence AB

Transaction: Rights issue

Issue volume: 11.0 MSEK

Date: November 2019

Raytelligence is a Swedish medtech company. The company offers a radar sensor, EaZense, that is capable of measuring position, motion patterns and respiration of humans in proximity of the sensor. The technology behind the sensor is based on the company’s proprietary platform. Raytelligence delivers its sensors and related services to healthcare and industry.

Raytelligence’s shares are listed on NGM Nordic MTF.

Augment acted as financial advisor to the company in the rights issue.